General MedicationsORALGeneric
IMIPRAMINE HYDROCHLORIDE
IMIPRAMINE HYDROCHLORIDE
Standard Dose
25MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview IMIPRAMINE HYDROCHLORIDE is listed in Drugs@FDA under application 086765 (ANDA).
Marketing status: Discontinued Active ingredient IMIPRAMINE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - 25MG/ML Sponsor NOVARTIS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview IMIPRAMINE HYDROCHLORIDE is listed in Drugs@FDA under application 086765 (ANDA). Marketing status: Discontinued Active ingredient IMIPRAMINE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - 25MG/ML Sponsor NOVARTIS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.